1. Fernandez-Balsells, M.M., et al., Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. The Journal of Clinical Endocrinology & Metabolism, 2011. 96(4): p. 905-912.
2. Feldkamp, J., et al., Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas-results of a prospective study. Clinical endocrinology, 1999. 51(1): p. 109-113.
3. Arita, K., et al., Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. Journal of neurosurgery, 2006. 104(6): p. 884-891.
4. Sanno, N., et al., A survey of pituitary incidentaloma in Japan. European Journal of Endocrinology, 2003. 149(2): p. 123-127.
5. Day, P.F., et al., Retrospective multicentric study of pituitary incidentalomas. Pituitary, 2004. 7(3): p. 145-148.
6. Reincke, M., et al., The'incidentaloma'of the pituitary gland. Is neurosurgery required? The Journal of the American Medical Association, 1990(20): p. 2772-2776.
7. Donovan, L.E. and B. Corenblum, The natural history of the pituitary incidentaloma. Archives of internal medicine, 1995. 155(2): p. 181-183.
8. Asa, S.L, et al., Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know? Endocrine Pathology, 2021.32(1): р3-16.
9. Taniguchi-Ponciano, K, et al., Molecular alterations in non-functioning pituitary adenomas. Cancer Biomarker, 2020. 28(2): 193-199.
10. Elsarrag, M, et al., Genomic and molecular characterization of pituitary adenoma pathogenesis: review and translational opportunities. Neurosurgical Focus, 2020. 48(6): p11.
11. Aflorei, E.D, et al., Epidemiology and etiopathogenesis of pituitary adenomas. Journal of neuro-oncology, 2014. 117(3): p.379-394..
12. Newey, P.J., et al., Whole-exome sequencing studies of nonfunctioning pituitary adenomas. The Journal of Clinical Endocrinology & Metabolism, 2013. 98(4): p. E796-E800.
13. Xiao, J.Q, et al., Correlations of pituitary tumor transforming gene expression with human pituitary adenomas: a meta-analysis. PLoS One, 2014. 9(3):e90396.
14. Thakker, R.V., Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Molecular and cellular endocrinology, 2014. 386(1-2): p. 2-15.
15. Vasilev, V, et al., Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas. Hormone and Metabolic Research, 2020. 52(8): p.553-561.
16. Hernandez-Ramirez, L.C., et al., Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers. The Journal of Clinical Endocrinology & Metabolism, 2015. 100(9): p. E1242-E1254.
17. Verges, B., et al., Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. The Journal of Clinical Endocrinology & Metabolism, 2002. 87(2): p. 457-465.
18. Beckers, A., et al., Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocrine reviews, 2013. 34(2): p. 239-277.
19. Osamura, R.Y., Pathology of pituitary tumors update: with World Health Organization new classification 2017. AJSP: Reviews & Reports, 2017. 22(4): p. 189-195.
20. Mayson, S.E. and P.J. Snyder, Silent (clinically nonfunctioning) pituitary adenomas. Journal of neuro-oncology, 2014. 117(3): p. 429-436.
21. Buurman, H. and W. Saeger, Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. European Journal of Endocrinology, 2006. 154(5): p. 753-758.
22. Kim, J.-H., et al., The characteristics of incidental pituitary microadenomas in 120 Korean forensic autopsy cases. Journal of Korean medical science, 2007. 22(Suppl): p. S61-S65.
23. Auer, R.N., P. Alakija, and G.R. Sutherland, Asymptomatic large pituitary adenomas discovered at autopsy. Surgical neurology, 1996. 46(1): p. 28-31.
24. Kastelan, D. and M. Korsic, High prevalence rate of pituitary incidentaloma: Is it associated with the age-related decline of the sex hormones levels? Medical hypotheses, 2007. 69(2): p. 307-309.
25. Al-Dahmani, K, et al., Sellar masses: an epidemiological study. Canadian Journal of Neurol ogical Sciences, 2016. 43(2): p. 291-297.
26. Vasilev, V., et al., Management of endocrine disease: pituitary ‘incidentaloma’: neuroradiological assessment and differential diagnosis. European journal of endocrinology, 2016. 175(4): p. R171-R184.
27. IGARASHI, T., N. SAEKI, and A. YAMAURA, Long-term Magnetic Resonance Imaging Follow-up of Asymptomatic Sellar Tumors—Their Natural History and Surgical Indications—. Neurologia medico-chirurgica, 1999. 39(8): p. 592-599.
28. Vernooij, M.W, et al., Incidental findings on brain MRI in the general population. New England Journal of Medicine, 2007. 357: p.1821-1828.
29. Oyama, K, et al., Management of pituitary incidentalomas: according to a survey of pituitary incidentalomas in Japan. Seminars Ultrasound CT MRI, 2005. 26(1): p.47-50.
30. Zada, G., et al., Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurgical Focus, 2010. 28(4): p. E4.
31. Esteves, C, et al., Pituitary incidentalomas: analysis of a neuroradiological cohort. Pituitary, 2015. 18(6): p.777-781.
32. Ezzat, S., et al., The prevalence of pituitary adenomas: a systematic review. Cancer: Interdisciplinary International Journal of the American Cancer Society, 2004. 101(3): p. 613-619.